Australia markets close in 2 hours 4 minutes

CureVac N.V. (5CV.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.3780+0.0340 (+1.45%)
At close: 05:51PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
53,758
53,758
67,420
102,990
48,871
Cost of revenue
124,366
124,366
183,993
238,195
14,173
Gross profit
-70,608
-70,608
-116,573
-135,205
34,698
Operating expenses
Research development
115,724
115,724
62,550
815,907
113,808
Selling general and administrative
76,433
76,433
89,411
88,857
45,663
Total operating expenses
205,654
205,654
134,279
277,058
144,513
Operating income or loss
-276,262
-276,262
-250,852
-412,263
-109,815
Interest expense
2,493
2,493
3,707
10,338
22,103
Total other income/expenses net
2,055
2,055
1,395
-
-
Income before tax
-259,969
-259,969
-249,155
-412,498
-129,848
Income tax expense
198
198
-126
-782
-726
Income from continuing operations
-260,167
-260,167
-249,029
-411,716
-129,122
Net income
-260,167
-260,167
-249,029
-411,716
-129,122
Net income available to common shareholders
-260,167
-260,167
-249,029
-411,716
-129,122
Basic EPS
-1.47
-
-1.32
-2.21
-0.98
Diluted EPS
-1.47
-
-1.32
-2.21
-0.98
Basic average shares
212,896
-
189,075
186,013
132,196
Diluted average shares
212,896
-
189,075
186,013
132,196